| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/14/2010 | WO2010004176A1 Mutations in the ns5b protein of the hcv |
| 01/14/2010 | WO2010004096A2 Culture of cells |
| 01/14/2010 | WO2010004004A1 Recombinant fibrinogen |
| 01/14/2010 | WO2010003943A1 New enzymatic active enzyme against clostridium |
| 01/14/2010 | WO2010003811A1 Amphiphilic proteins as morphology modifiers |
| 01/14/2010 | WO2010003766A2 Multimeric tnf receptors |
| 01/14/2010 | WO2010003668A2 Treatment of solid tumors with tissue inhibitors of metalloproteinases (timps) |
| 01/14/2010 | WO2010003635A1 Modulation of the immune response by means of the nkp65 receptor and the clec2a ligand thereof |
| 01/14/2010 | WO2010003529A1 Method of providing immunoglobulin secreting b lymphocytes and human antibodies |
| 01/14/2010 | WO2010003245A1 Soluble canola protein isolate production |
| 01/14/2010 | WO2010003240A1 Gmcsf and truncated ccl2 conjugates and methods and uses thereof |
| 01/14/2010 | WO2010003235A1 Soluble recombinant influenza antigens |
| 01/14/2010 | WO2010003231A1 Multi-leu peptides and analogues thereof as selective pace4 inhibitors and effective antiproliferative agents |
| 01/14/2010 | WO2010003230A1 Monoclonal antibodies developed to clostridium botulinum flagellin proteins: novel detection reagents |
| 01/14/2010 | WO2010003225A1 Influenza virus-like particles (vlps) comprising hemagglutinin |
| 01/14/2010 | WO2010003193A1 Peptide inhibitors of cd40l signaling and uses therefor |
| 01/14/2010 | WO2010003184A1 Enzymes and methods for hydrolysing phenylureas, carbamates and organophosphates |
| 01/14/2010 | WO2010003170A1 Novel receptor hetero-dimers/-oligomers |
| 01/14/2010 | WO2009143067A3 Methods, devices, kits and compositions for detecting whipworm |
| 01/14/2010 | WO2009137254A3 Modified factor ix polypeptides and uses thereof |
| 01/14/2010 | WO2009126463A3 Filamentous fungi with inactivated protease genes for altered protein production |
| 01/14/2010 | WO2009117307A3 Viruses lacking epithelial cell receptor entry |
| 01/14/2010 | WO2009058564A3 Immunosuppressive polypeptides and nucleic acids |
| 01/14/2010 | WO2009055111A3 Human laminin receptor crystal and uses thereof |
| 01/14/2010 | WO2008157378A8 Rage fusion proteins |
| 01/14/2010 | WO2008154351A9 Rtef-1 variants and the use thereof for inhibition of angiogenesis |
| 01/14/2010 | WO2008150821A8 Modified nucleotide sequence encoding glucagon-like peptide-1 (glp-1) |
| 01/14/2010 | WO2008106662A3 Nitrilases, nucleic acids encoding them and methods for making and using them |
| 01/14/2010 | WO2006110413A9 Haemophilus influenzae type b |
| 01/14/2010 | WO2003083054A9 Amylases, nucleic acids encoding them and methods for making and using them |
| 01/14/2010 | WO2003064603A9 Nucleic acid molecule encoding iwu-1 |
| 01/14/2010 | WO2002072609A9 Neuroactive peptides for prevention and/or treatment of hypoxia and neuropathic pain |
| 01/14/2010 | US20100011468 Fungus resistant plants and their uses |
| 01/14/2010 | US20100011467 Method for increasing resistance to pathogens in transgenic plants |
| 01/14/2010 | US20100011466 Signal Transduction Stress-Related Proteins and Methods of Use in Plants |
| 01/14/2010 | US20100011460 Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots |
| 01/14/2010 | US20100011456 Nucleic Acids and Proteins and Methods for Making and Using Them |
| 01/14/2010 | US20100011453 Model for muscular dystrophy and cardiomyopathy |
| 01/14/2010 | US20100011452 Chimeric non-human animal |
| 01/14/2010 | US20100010201 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
| 01/14/2010 | US20100010200 for Systemic Inflammatory Response Syndrome (SIRS), including severe sepsis, septic shock and sepsis related to cardiac dysfunction |
| 01/14/2010 | US20100010198 Soluble Canola Protein Isolate Production ("Nutratein") |
| 01/14/2010 | US20100010197 Method and system for corn fractionation |
| 01/14/2010 | US20100010196 Compositions and methods for non-targeted activation of endogenous genes |
| 01/14/2010 | US20100010195 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 01/14/2010 | US20100010187 Glucosamine materials |
| 01/14/2010 | US20100010075 COMPOUNDS FOR ELICITING OR ENHANCING IMMUNE REACTIVITY TO HER-2/neu PROTEIN FOR PREVENTION OR TREATMENT OF MALIGNANCIES IN WHICH THE HER-2/neu ONCOGENE IS ASSOCIATED |
| 01/14/2010 | US20100009923 Antigens Targeted by Pathogenic Al4 T Cells in Type 1 Diabetes and Uses Thereof |
| 01/14/2010 | US20100009920 Ttk as tumor marker and therapeutic target for lung cancer |
| 01/14/2010 | US20100009917 Modulating Enzymatic Processes by Addition of Diolcontaining Substances |
| 01/14/2010 | US20100009916 Selective vpac2 receptor peptide agonists |
| 01/14/2010 | US20100009913 Uses for Yerba Santa |
| 01/14/2010 | US20100009912 Insecticidal extract from legume plants and method of preparing the same |
| 01/14/2010 | US20100009909 Peptides binding the phosphatase 2a protein |
| 01/14/2010 | US20100009907 Glucagon-Like Peptides and Uses Thereof |
| 01/14/2010 | US20100009904 Modified Exedins and Uses Thereof |
| 01/14/2010 | US20100009899 Novel Insulin Derivatives |
| 01/14/2010 | US20100009898 Protease resistant insulin analogues |
| 01/14/2010 | US20100009897 Polypeptide having larvae growth inhibiting or insecticidal effect on scarabaeidae insects and polynucleotide encoding the same |
| 01/14/2010 | US20100009863 Method for engineering t-cell receptors |
| 01/14/2010 | US20100009463 Reagents for the detection of protein phosphorylation in signaling pathways |
| 01/14/2010 | US20100009461 Npcil1 (Npc3) And Methods Of Identifying Ligands Thereof |
| 01/14/2010 | US20100009452 Functional Peptide Having Activity of Stimulating Immune Cell |
| 01/14/2010 | US20100009447 Vgamma9Vdelta2 T cell proliferation agent, method for producing activated Vgamma9Vdelta2 T cells, and uses thereof |
| 01/14/2010 | US20100009444 System and method for controlling g-protein coupled receptor pathways |
| 01/14/2010 | US20100009438 Dendritic cell potentiation |
| 01/14/2010 | US20100009437 Isolated proteins MAGE-4 and MAGE-41 |
| 01/14/2010 | US20100009425 Glycoprotein synthesis |
| 01/14/2010 | US20100009409 Molecular variant fibrinogen fusion proteins |
| 01/14/2010 | US20100009366 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 01/14/2010 | US20100009363 RBP4 In Insulin sensitivity/resistance, diabetes, and obesity |
| 01/14/2010 | US20100009361 Compositions and methods for detecting noonan syndrome |
| 01/14/2010 | US20100009345 Compositions and methods comprising a ligand of chemerin R |
| 01/14/2010 | US20100008989 Process for manufacture of gelatin solutions and products thereof |
| 01/14/2010 | US20100008964 Isolated stromal cells and methods of using the same |
| 01/14/2010 | US20100008947 Porcine adenovirus e1 and e4 regions |
| 01/14/2010 | US20100008943 Extracellular matrix-binding proteins from staphylococcus aureus |
| 01/14/2010 | US20100008941 vaccination directed against the hepatitis C virus (HCV); |
| 01/14/2010 | US20100008936 IL-16 antagonist peptides and DNA encoding the peptides |
| 01/14/2010 | US20100008932 Use of soluble cd160 to suppress immunity |
| 01/14/2010 | US20100008926 Novel proteins and use thereof |
| 01/14/2010 | US20100008925 Methods and compositions for treatment of endotoxin-mediated pro-inflammatory responses |
| 01/14/2010 | US20100008924 Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
| 01/14/2010 | US20100008922 In Vivo Induced Genes of Mycobacterium Tuberculosis |
| 01/14/2010 | US20100008921 Diagnostic and Therapeutic Target Adarb2 Proteins for Neurodegenerative Diseases |
| 01/14/2010 | US20100008920 Reagents and Methods for Engaging Unique Clonotypic Lymphocyte Receptors |
| 01/14/2010 | US20100008905 Anti-idiotype monoclonal antibodies as mimotopes of the hiv gp120 antigen |
| 01/14/2010 | US20100008903 Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment |
| 01/14/2010 | US20100008895 used in vaccines against A. salmonicida infections such as fish disease furunculosis; ADP-ribosylating toxins |
| 01/14/2010 | US20100008871 New Biochemical Route to Astaxanthin |
| 01/14/2010 | CA2730408A1 Influenza hemagglutinin and neuraminidase variants |
| 01/14/2010 | CA2730316A1 Peptide inhibitors of cd40l signaling and uses therefor |
| 01/14/2010 | CA2730270A1 Dicarba-analogues of octreotide |
| 01/14/2010 | CA2730185A1 Influenza virus-like particles (vlps) comprising hemagglutinin |
| 01/14/2010 | CA2730171A1 Soluble recombinant influenza antigens |
| 01/14/2010 | CA2730152A1 Enzymes and methods for hydrolysing phenylureas, carbamates and organophosphates |
| 01/14/2010 | CA2730088A1 Immunity-inducing agent and method for detection of cancer |
| 01/14/2010 | CA2730030A1 Recombinant fibrinogen |
| 01/14/2010 | CA2729937A1 Fibromyalgia test method |
| 01/14/2010 | CA2729351A1 Fn14/trail fusion proteins |